Cardiac disease after radiation therapy for Hodgkin's disease: Analysis of 48 patients

1983 ◽  
Vol 51 (10) ◽  
pp. 1679-1681 ◽  
Author(s):  
Mark M. Applefeld ◽  
Peter H. Wiernik
Keyword(s):  
Radiation Therapy ◽  
Cardiac Disease ◽  
Hodgkin's Disease ◽  
Hodgkin’S Disease ◽  
Disease Analysis

Long-term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model

2000 ◽  
Vol 55 (2) ◽  
pp. 153-162 ◽  
Author(s):  
Fredrik Eriksson ◽  
Giovanna Gagliardi ◽  
Anette Liedberg ◽  
Ingmar Lax ◽  
Chung Lee ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Hodgkin's Disease ◽  
Hodgkin’S Disease ◽  
Cardiac Mortality ◽  
Disease Analysis

Probability of carcinogenesis due to involved field and involved site radiation therapy techniques for supra- and infradiaphragmatic Hodgkin’s disease

2019 ◽  
Vol 57 ◽  
pp. 100-106 ◽  
Author(s):  
Kalliopi M. Kourinou ◽  
Michalis Mazonakis ◽  
Efrosini Lyraraki ◽  
Helen Α. Papadaki ◽  
John Damilakis
Keyword(s):  
Radiation Therapy ◽  
Hodgkin's Disease ◽  
Hodgkin’S Disease ◽  
Involved Field

Radiation therapy for early stage Hodgkin's disease: Australasian patterns of care

1995 ◽  
Vol 31 (2) ◽  
pp. 227-236 ◽  
Author(s):  
Michael Barton ◽  
John Boyages ◽  
Elizabeth Crennan ◽  
Sidney Davis ◽  
Richard J. Fisher ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Hodgkin's Disease ◽  
Early Stage ◽  
Hodgkin’S Disease ◽  
Patterns Of Care

scholarly journals Involved field radiation therapy for early stage Hodgkin's disease in children.Preliminary results

Cancer ◽  
1976 ◽  
Vol 37 (4) ◽  
pp. 1625-1632 ◽  
Author(s):  
William C. Cham ◽  
Charlotte T. C. Tan ◽  
Alvaro Martinez ◽  
Philip R. Exelby ◽  
Melvin Tefft ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Hodgkin's Disease ◽  
Early Stage ◽  
Hodgkin’S Disease ◽  
Field Radiation ◽  
Involved Field

Reduction of fatal complications from combined modality therapy in Hodgkin's disease.

1985 ◽  
Vol 3 (4) ◽  
pp. 501-505 ◽  
Author(s):  
P M Mauch ◽  
G P Canellos ◽  
D S Rosenthal ◽  
S Hellman
Keyword(s):  
Radiation Therapy ◽  
Hodgkin's Disease ◽  
Hodgkin’S Disease ◽  
Combined Modality Therapy ◽  
Low Risk ◽  
Acute Nonlymphocytic Leukemia ◽  
Maintenance Chemotherapy ◽  
Fatal Complication ◽  
Actuarial Risk ◽  
Fatal Complications

A total of 464 pathologically staged IA through IIIB Hodgkin's disease patients were evaluated for the risk of developing acute nonlymphocytic leukemia, non-Hodgkin's lymphoma, or a fatal infection after treatment with radiation therapy (RT) alone, initial combined radiation therapy and chemotherapy (CMT), or RT with MOPP administered at relapse. Patients received a standard six cycles of MOPP, and additional maintenance chemotherapy was not administered. Patients receiving total nodal irradiation (TNI) and MOPP chemotherapy have an 11.9% actuarial risk of developing a fatal complication at ten years, as compared to a 0.8% risk for lesser field irradiation and MOPP (P = .005). The risk with RT alone is 0.6%. Patients 40 years of age or older have a greater risk for complications. These data report a low risk for fatal complication with CMT when less than TNI is administered and when maintenance chemotherapy is not used.

Sign in / Sign up

Export Citation Format

Share Document